Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

Completed · Phase 4

Conditions studied: Schizophrenia

In brief

The purpose of this study is to evaluate medication satisfaction after at least 4 weeks of paliperidone ER (extended-release), an antipsychotic, treatment in patients with schizophrenia who were previously taking either 4 or 6 mg of risperidone daily by mouth, but who are not satisfied with their treatment.

Key facts

Study ID

NCT00535132

Run by

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

People needed

201

Starts

2007-10-01

Expected to finish

2008-07-01

Last updated by the study team

2014-05-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be able to understand, in the opinion of the investigator, the informed consent form.
• be diagnosed with schizophrenia
• report dissatisfaction with current medication
• have an aspect of schizophrenia management which could potentially benefit from a change in antipsychotic medication
• receive risperidone 4 mg or 6 mg for at least 4 weeks before the start of the study.

You may not qualify if…

• Unable to swallow study drug whole with the aid of water
• cannot have received an investigational drug, used an investigational medical device, or participated in a clinical study that altered their medication within 6 months before the first administration of study drug, or have participated in more than 2 investigational drug studies within the past 12 months
• no other major mental health diagnosis except for tobacco dependance
• no use of cocaine or heroin within 3 months before the first administration
• no history of treatment with any antipsychotic in addition to treatment with risperidone, or treatment with paliperidone, within 30 days before the baseline visit.

Where it is running

• Study site — Cerritos, California, United States
• Study site — Garden Grove, California, United States
• Study site — Huntington Beach, California, United States
• Study site — Pico Rivera, California, United States
• Study site — San Diego, California, United States
• Study site — Santa Ana, California, United States
• Study site — Torrance, California, United States
• Study site — Atlanta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Flowood, Mississippi, United States
• Study site — Clementon, New Jersey, United States
• Study site — Brooklyn, New York, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Austin, Texas, United States
• Study site — Irving, Texas, United States
• Study site — Miami, FL, Argentina
• Study site — Buenos Aires, Argentina
• Study site — Ciudad Autonoma de, Argentina
• Study site — Cordoba Crd, Argentina
• Study site — Mendoza, Argentina
• Study site — Mendoza Men, Argentina
• Study site — Rosario, Argentina
• Study site — Barranquilla, Colombia
• Study site — Bogotá, Colombia
• Study site — Bogotá S/N, Colombia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.